Eccrine Systems’ CEO to Present at Digital Medicine & Medtech ShowcaseTM 2020 in San Francisco

As CEO, Gavi Begtrup, Ph.D., will provide an overview of the company and its non-invasive medication monitoring platform for precision dosing and adherence monitoring.

Presentation Details

Dr. Begtrup and Mark Tierney, SVP of Commercialization, will be available for partnering and investment discussions from January 13-16 and throughout the Biotech Showcase™ and Digital Medicine & Medtech Showcase 2020.

ABOUT ECCRINE SYSTEMS, INC.
Eccrine Systems is individualizing the prescription of medicine with a breakthrough platform for remote, non-invasive, and quantitative medication monitoring through sweat. This breakthrough technology enables providers to personalize pharmacotherapy across applications ranging from opioid compliance to precision dosing of narrow therapeutic index drugs in oncology and organ transplant — addressing a $500B/year problem in U.S. healthcare. To learn more, please visit www.eccrinesystems.com.

ABOUT DIGITAL MEDICINE & MEDTECH SHOWCASE
Digital Medicine & Medtech Showcase is the dedicated home for the digital health and medtech communities during Biotech Showcase™ and one of the healthcare industry’s biggest weeks. Taking place January 13–15, Digital Medicine & Medtech Showcase includes three days of networking opportunities, curated presentations and specialized sessions. These program elements create a forum for innovative digital medicine and medtech companies to plan for successful partnerships and evaluate growth prospects in a shifting healthcare market. Attendees are able to schedule one-to-one meetings using partneringONE® and have full access to the concurrent event, Biotech Showcase™.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200110005080/en/